Humacyte, Inc.
已更新

FDA APROVAL

180
HUMA had a significant decline with DELAY in approval over something minor, still waiting see if it holds the 100MA and gets approval. ANALSYTS PREDICT 11$
Some insider selling and possible dilution. Watching 👀
交易進行
Still holding W 100MA. Director buys 4600 shares today at $4.38. Possible further delays in the future
OR approval for strong gap up whispers are word this week either way.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。